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Abstract
Background: Thyroid cancer is the most common endocrine tumor with a steady increase in incidence. It is
classified into multiple histopathological subtypes with potentially distinct molecular mechanisms. Identifying the
most relevant genes and biological pathways reported in the thyroid cancer literature is vital for understanding of
the disease and developing targeted therapeutics.
Results: We developed a large-scale text mining system to generate a molecular profiling of thyroid cancer
subtypes. The system first uses a subtype classification method for the thyroid cancer literature, which employs a
scoring scheme to assign different subtypes to articles. We evaluated the classification method on a gold standard
derived from the PubMed Supplementary Concept annotations, achieving a micro-average F1-score of 85.9% for
primary subtypes. We then used the subtype classification results to extract genes and pathways associated with
different thyroid cancer subtypes and successfully unveiled important genes and pathways, including some
instances that are missing from current manually annotated databases or most recent review articles.
Conclusions: Identification of key genes and pathways plays a central role in understanding the molecular biology
of thyroid cancer. An integration of subtype context can allow prioritized screening for diagnostic biomarkers and
novel molecular targeted therapeutics. Source code used for this study is made freely available online at https://
github.com/chengkun-wu/GenesThyCan.
Background
Thyroid cancer (TC) is the most common endocrine
malignancy [1] and its incidence increase has been sig-
nificant in recent years despite some controversies about
the extent [2]. Many possible factors causing thyroid
cancer have been reported including exposure to ionis-
ing radiation, iodine-deficiency and heredity [3]. Con-
ventional treatment strategies include surgical resection,
radiation therapy (especially radioactive iodine therapy),
chemotherapy and thyroid hormone therapy [4]. How-
ever, the understanding of the underlying molecular
mechanisms is still incomplete.
Thyroid tumours are usually classified into multiple
subtypes according to their histopathological character-
istics, and treatments are selected depending on the sub-
type and stage of thyroid cancer. The main subtypes
include papillary thyroid cancer (PTC), follicular thyroid
cancer (FTC), anaplastic thyroid cancer (ATC) and
medullary thyroid cancer (MTC) [4]. PTC and FTC are
also sometimes collectively referred to as differentiated
thyroid cancer (DTC) or well-differentiated thyroid can-
cer (WDTC), while ATC can also be referred to as
undifferentiated thyroid cancer. In addition, a number
of rare subtypes have been described. Cellular origins
and some of the known molecular mechanisms differ
for each subtype [5], which may include subtype-specific
alterations in DNA methylation patterns [3] and have
led to new therapeutic approaches based on the molecu-
lar signature of the tumours.
* Correspondence: goran.nenadic@manchester.ac.uk
3Manchester Institute of Biotechnology, 131 Princess Street, Manchester M1
7DN, UK
Full list of author information is available at the end of the article
Wu et al. BMC Medical Genomics 2014, 7(Suppl 3):S3
http://www.biomedcentral.com/1755-8794/7/S3/S3
© 2014 Wu et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
These “targeted therapeutics” of thyroid cancer are being
rapidly developed [6,7]. Several potential drugs are cur-
rently in preclinical testing or in clinical use [8,9]. How-
ever, lack of systematic studies of underlying molecular
mechanisms can lead to a high risk for thyroid cancer
patients, who might suffer from unexpected side effects.
For instance, RET has been shown to be an oncogene in
thyroid cancer but is considered as a potential tumour
suppressor gene in colorectal cancer [10]. Consequently,
studies focusing on one or a few genes are likely to miss
the molecular context that could be vital for a comprehen-
sive understanding of the disease.
For systematic studies, a major challenge is to effi-
ciently utilise the myriad of knowledge and information
from unstructured scientific literature. PubMed, one of
the most widely used systems for biomedical literature
search [11], returns over 50,000 results with the search
query ‘thyroid cancer’. The number is increasing rapidly,
with over 2,000 articles published annually in recent
years, as illustrated in Figure 1. This trend has made it
extremely difficult for scientists to identify, retrieve and
assimilate all relevant publications.
To support the identification and retrieval of relevant
articles, MeSH (Medical Subject Headings, http://www.
nlm.nih.gov/pubs/factsheets/mesh.html) terms are used
in PubMed to label the topic of each document, along
with additional headings known as Supplementary Con-
cepts (SCs). The MeSH term used for thyroid cancer is
‘thyroid neoplasms’, and the major subtypes are repre-
sented as SCs. However, the thyroid cancer SCs were
only introduced in August 2010, which means the
majority of the thyroid cancer literature does not have a
subtype label indicated by SC.
Text mining techniques have been extensively used to
support access to the biomedical literature [12,13]. A
number of tasks can now be successfully fulfilled by text
mining, including gene mention recognition and nor-
malization [14,15], pathway mention recognition [16]
and event extraction [17,18]. Those efforts enable the
extraction of structured and explicit data, and this
further targets the exploration and investigation of spe-
cific biological questions.
In this paper we focus on identifying genes and path-
ways that are reported in the thyroid cancer literature,
grouped by subtypes. We then compare our systematic
effort to some established databases and demonstrate
how our results could boost the understanding of thyr-
oid cancer and promote comprehensive investigation for
potential therapeutic targets.
Related work
There are several curated databases that contain mole-
cular information of thyroid cancer. For example, the
Thyroid Cancer and Disorder Gene Database (TCGDB,
http://www.juit.ac.in/attachments/tcgdb/) contains infor-
mation about genes and miRNAs involved in different
thyroid cancer subtypes. The data in TCGDB have been
extracted through manual literature review of a few
selected articles. However, details of these articles are
not revealed, so it is not clear how systematic and com-
prehensive the database is.
MalaCards is a generic integrated compendium for dis-
eases and associated annotations [19], with some informa-
tion related to TC. It provides disease-specific information
from multiple sources, including related publications,
genes and pathways. However, there are several limita-
tions: firstly, the publications associated with a disease are
obtained by title search only, which could miss out many
relevant articles; secondly, pathways are provided by
affiliated genes rather than their mentions in the literature.
Figure 1 Number of PubMed articles returned by the ‘thyroid cancer’ query. The size of thyroid cancer related literature is increasing
rapidly, with over 2,000 articles published annually in recent years.
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Finally, the coverage of this data set is limited: for example,
a search for “anaplastic thyroid cancer” returns no
affiliated genes.
Gene2Pubmed [20] is a generic database maintained by
NCBI that provides a set of manually added links from
PubMed articles to genes. Gene2Pubmed integrates infor-
mation from a number of public databases and the links
are not limited to articles specifically defining the function
of a given gene. However, similarly to other resources, its
coverage is limited: for example, we found quite a few
examples where TC-related genes were missing from the
Gene2Pubmed annotation (see Results).
Several databases contain information about pathways
and their associations to diseases. KEGG [21], for exam-
ple, contains pathways for different diseases, but its cov-
erage is often limited, in particular for diseases that are
not widely studied (e.g. there is a single pathway dia-
gram for thyroid cancer). Even for databases that focus
on specific diseases (e.g. AlzPathway [22] is a database
of pathways associated to Alzheimer’s disease) it is often
difficult to keep up with new findings through manual
curation, and automated text mining approaches need
to be used to ensure a wider coverage [16].
There are various efforts to automatically extract rela-
tionships between cancer and its molecular bases from
the literature. For instance, a maximum entropy-based
named entity recognizer and relation recognizer were
applied to find relations between prostate cancer and
genes [23]. Other relation finding tools can be applied
to cancer related studies as well, including FACTA [24],
CoPub [25], DigSee [26] and OncoSearch (http://onco-
search.biopathway.org). Both FACTA and CoPub sup-
port searching for co-occurring biomedical concepts
(genes/diseases), facilitated by indexing through diction-
ary matching or regular expression matching. DigSee
and OncoSearch can scan the literature to identify
whether a gene is up-regulated or down-regulated in a
particular type of cancer. The systems look for genes
that are reported together with a biological event and
cancer in the same sentence. While the results are
therefore often highly accurate, they may not be com-
prehensive. However, no systems could support extrac-
tion of information specific to thyroid cancer subtypes.
Methods
Pipeline for generating the molecular profiling
The pipeline we engineered to generate the molecular pro-
filing of thyroid cancer subtypes is depicted in Figure 2.
It starts with the corpus construction and is followed by
the text mining tasks implemented as annotators within
TextPipe [18], a framework designed for large-scale, mod-
ular text processing and data integration. Text mining
results are then used to find the association between
genes/pathways and thyroid cancer subtypes. These stages
are explained in the following subsections.
Data - a corpus of thyroid cancer from MEDLINE
All the documents in our corpus were retrieved from
MEDLINE. We performed a PubMed search with the
query “(((thyroid neoplasms[majr] AND human[mh] AND
english[la]) OR thyroid[ti]) AND (cancer OR carcinoma
OR malignant OR malignancy))“, as suggested by the
National Cancer Institute for retrieving the TC-relevant
literature (see http://www.cancer.gov/cancertopics/lit-
search/endocrine). It should be noted that the query limits
the results to human studies in English. A total of 38,572
PubMed IDs (PMIDs) were fetched from PubMed
(accessed on 13/01/2014). The complete list of PMIDs is
available in Additional File 1. We retrieved abstracts from
PubMed using those PMIDs and constructed the thyroid
cancer corpus (TC_TEXT) using PyPubmedText, which
is freely available from https://github.com/chengkun-wu/
PyPubmedText.
For the evaluation, we created the SC_GOLD corpus,
which consists of all 1,213 documents with specified
subtype SCs since their introduction in 2010 (see Addi-
tional File 2).
Subtype classification using subtype scoring
For subtype classification, we aimed to label the articles
in the TC_TEXT corpus with the major TC subtype(s)
discussed in the associated abstract. The subtypes we
investigated included PTC, ATC, FTC and MTC. We
considered this as a document classification task and
have developed an efficient classification method based
on a subtype-scoring scheme. Although machine-learn-
ing methods are popular for document classification
[27], we did not employ them here due to insufficient
training data for each of the TC subtypes: while the
recent articles with SCs can be used as the training
data, the number of documents is still limited (1,213 in
total, much fewer for each subtype). Instead, we used a
flexible dictionary matching method as described below.
For each article in the corpus, we calculate a vector of
scores corresponding to each TC subtype through the
following steps:
1. Subtype names are often mentioned partially and
in abbreviated forms, due to language economy and
flexibility (e.g. “...Inflammatory infiltrates could
increase the risk of papillary cancer in patients with
autoimmune lymphocytic thyroiditis...” (PMID:
21042739)). We therefore dissociate each subtype
name into three parts: (1) subtype keyword (SK); (2)
anatomy keyword (AK); (3) malignancy keyword
(MK). For instance, in “papillary thyroid cancer”, the
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SK is “papillary”, the AK is “thyroid” and the MK is
“cancer”. We then match those parts against text
separately, maintaining the three separate keyword
lists for matching: a subtype keyword list, an anat-
omy keyword list and a malignancy keyword list. For
each list, possible variants are also included. For
instance, “anaplastic thyroid cancer” is also named
as “undifferentiated thyroid cancer”, which can be
written as “un-differentiated thyroid cancer”. So
“anaplastic”, “un-differentiated” and “undifferen-
tiated” will all be mapped to “anaplastic”. The lists
are included in the additional files. For matching, we
applied the open-source package LINNAEUS [28].
2. Each input document is split into sentences. For
each sentence, we apply dictionary matching to cal-
culate the subtype relevance scores of that sentence
calculated as follows: (1) if SK co-occurs within that
sentence with both AK and MK, then the sentence
has a relevance score 1 to the subtype SK; (2) if SK
co-occurs with only AK or MK, then the sentence
has a relevance score 0.5 to the subtype SK; (3) if SK
appears alone without the presence of either AK or
MK, the sentence has a relevance score 0.25 to the
subtype SK. We defined these rules to cover the
situations where subtype names are simplified, as
illustrated above.










for article di is calculated by weighted accumulation
of the vectors of subtype scores for each sentence
(the four elements in Si correspond to PTC, ATC,
FTC and MTC respectively). The weights of differ-
ent sentences are assigned in the following way: the
title of a document is considered as the most impor-
tant element and is assigned a weight of 4; the first
sentence in the abstract usually mentions the main
topic of the document and the last sentence usually
concludes the article, and both are assigned a weight
of 2; the second and the penultimate sentence can
be quite important as well, and are both assigned a
weight of 1; other sentences in the abstract are given
a weight of 0.5 in order to weaken bypassing men-
tions of subtype names that are not the major scope
of the article.
For classification, we set threshold values for each
subtype and assign the corresponding label to the article
if the associated subtype score is above a pre-set value.
We assigned slightly different thresholds to different
subtypes, with the PTC’s percentage threshold slightly
higher than other subtypes, given that PTC occurs more
frequently in the literature (over 50%).
Gene recognition and normalisation
A number of tools are available for identifying mentions
of genes in the literature and normalising them to data-
base identifiers. We utilized two open source libraries,
Moara [14] and GNAT [15], which have been success-
fully applied in other studies [18,26]. For gene name
recognition, Moara utilizes the CBR-tagger [29], which
treats the recognition problem as a binary classification
on each token; GNAT employs dictionary-expanded reg-
ular expressions together with BANNER [30]. For the
normalisation of recognized gene names, both tools map
mentions to the Entrez Gene database [20], adopting
similar methods for disambiguation. We wrapped Moara
and GNAT as TextPipe annotators that output normal-
ised gene mentions including document ID (PubMed
ID), positions in the text, normalised Entrez Gene ID,
original text and the applied tool (Moara or GNAT). If
the two tools report overlapping mentions, we created a
new one covering both mentions (union); if the overlap-
ping mentions have been assigned different Entrez Gene
identifiers, the priority is given to GNAT as its reported
performance is higher.
Pathway mention recognition
We utilised PathNER for pathway mention recognition
from the literature [16]. PathNER is implemented using
soft dictionary matching and manually created rules. For
this study, we recompiled the pathway dictionary using
Figure 2 The pipeline to generate the molecular profiling of thyroid cancer subtypes. The pipeline starts with corpus construction, which
is followed by text mining annotators implemented within the TextPipe framework. The text mining results are then used to find genes/
pathways association with thyroid cancer subtypes, which lead to a comprehensive molecular profiling of primary thyroid cancer subtypes.
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the data from the 2013 update of the ConsensusPathDB
interaction database [31]. The outputs from this annota-
tor are biological pathway mentions including document
ID (PubMed ID), positions in the text, pathway database
identifier (if available) and original text.
Association between genes/pathways and subtypes
To establish the association between text-mined informa-
tion and thyroid cancer subtypes, we performed the follow-
ing steps for each text-mined entity (gene or pathway,
referred to as E thereafter):
1. Get all the documents DE = {di|i ∈ [1,n]} that
mention E according to the text-mining results;





























SMi 〉 = 〈SPE, SAE , SFE, SME 〉
For a given subtype j ∈ {P,A, F,M}, we generate a list of
entities Lj, which is composed of entities that have at least
one document labelled as subtype j in the classification
stage; we then rank the entities in Lj = [E1,E2, · · · ,Ek] in a
descending order by the value of SjE for each entity E in Lj.
Results and discussion
Subtype classification evaluation
For performance assessment against the gold standard,
we adopted the standard metrics: Precision (P), Recall







, F1 = 2
P · R
P + R
Here, TP is the number of true positives, FP is the
number of false positives and FN is the number of false
negatives. Those metrics were calculated for each sub-
type. For documents with multiple subtype labels, the
labels were evaluated separately.
The evaluation of the classification performance
against the SC_GOLD corpus for each TC subtype is
listed in Table 1. The performance for PTC, ATC and
MTC shows good precision and moderate recall, with
F1-score over 85%. This demonstrates the effectiveness
of our scoring scheme.
Unexpectedly, the precision for FTC was low (17.5%).
We therefore performed error analysis to investigate the
reason for that. We found that more than half of all
errors (54 of the 99 FPs for FTC) are from articles
about DTC or WDTC, referring to both PTC and FTC
[32]. However, it seems that the PubMed SCs typically
only annotate an article with PTC if it is about DTC.
This is probably because the SC for FTC was introduced
in August 2012, while the SC for PTC was introduced
two years earlier. If those 54 cases are considered TPs
then the performance is obviously improved (F1 is
72.5%; listed in Table 1 as FTC*). We also found a few
other variants such as “follicular variant papillary carci-
noma”, “mixed medullary-follicular carcinoma of the
thyroid”, “follicular variant of PTC”, etc. We checked
the frequency of those variants by dictionary matching
and we found them in 31 documents in SC_GOLD. As
our classification “dissects” thyroid cancer subtype
names into several parts, follicular variants will score
and get incorrectly classified as FTC in those situations.
The FTC precision is thus more affected as “follicular”
is a word commonly used in PTC articles, since PTCs
are derived from follicular cells [33].
In Table 1, we also listed the performance of a base-
line method for comparison. The baseline method per-
forms classification based on subtype name occurrences
in titles and abstracts by dictionary matching using LIN-
NAEUS [28]. The dictionary includes all available syno-
nyms for the TC subtype names. The performance
results demonstrate that our method outperforms the
baseline for all subtypes.
Application to TC_TEXT
We ran our classification method on the whole
TC_TEXT corpus (38,572 abstracts). The complete clas-
sification results (with subtype relevancy scores and pre-
dicted labels) can be found in Additional File 3. The
number of articles labelled with each subtype is listed in
Table 2, which also shows the incidence rate of each
Table 1 TC subtype classification performance on the
SC_GOLD corpus.
TP TN FN FP Precision Recall F1
Our
Method
PTC 641 372 186 14 0.979 0.775 0.865
ATC 114 1066 27 6 0.950 0.809 0.874
FTC 21 1081 12 99 0.175 0.636 0.275
FTC* 75 1081 12 45 0.625 0.862 0.725
MTC 189 979 41 4 0.979 0.822 0.894
Micro
Average
1019 3498 266 69 0.937 0.793 0.859
TP TN FN FP Precision Recall F1
Baseline PTC 601 372 226 14 0.977 0.727 0.834
ATC 109 1063 32 9 0.924 0.773 0.842
FTC 19 1061 14 119 0.320 0.485 0.386
FTC* 73 1061 14 65 0.529 0.839 0.649
MTC 181 971 49 12 0.938 0.787 0.856
Micro
Average
964 3467 321 100 0.906 0.750 0.821
FTC* is the result after adjusting the results by considering WDTC. The micro-
average calculation uses FTC*.
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subtype. We can see that the amount of literature some-
what reflects the incidence rate, with PTC as the most
frequent and ATC as the least frequent among the four
subtypes studied here. The results also show that it is
relatively uncommon to discuss more than one subtype
in an article (see Figure 3), with the exception of PTC
and FTC, which are frequently studied together as they
are both derived from follicular cells [33].
Gene normalization results and gene-subtype association
We ran gene recognition and normalization on the
TC_TEXT corpus and a total number of 2,833 unique
genes were detected. We first compared the resulting list
against the gene list generated from the Gene2Pubmed
database [20]. Out of 914 genes identified in Gene2-
Pubmed, 762 (83.4%) are found by our text mining
approach. On the other hand, 2,071 out of 2,833 text-
mined genes (73.1%) are not listed in the Gene2Pubmed
database (see Figure 4). We randomly sampled 50 genes
from that difference set and manually checked whether
they are associated with TC or not. Table 3 shows these
genes sorted by their document-level frequency, according
to text mining results. If a gene is related to TC, an exam-
ple of relevant document is given. Overall, 42 genes out of
50 are found to be reported as associated with thyroid can-
cer. This highlights the importance of using text mining
for a comprehensive retrieval of information, complement-
ing manually annotated data, which may potentially miss
over 1,700 TC-related genes (84% of 2,071). We also note
that even genes with low document-level frequencies can
be relevant: for instance, WNT7A (Entrez Gene ID: 7476)
was only detected once by text mining, but is reported to
be over expressed in both PTC and its aggressive variant.
Therefore, we did not use any filters based on document-
level frequency in this study.
With the subtype classification, we generated ranked
gene lists for each subtype as discussed in the Methods
section (see Table 4 for the statistics). The top 20 genes
for each subtype are given in Table 5 (the full results
are provided in Additional File 4). The genes are ranked
in descending order by their subtype scores (as
described in Methods section). To validate the results,
we looked at the most recent review on thyroid cancer
[34]. Almost all well-observed mutations (see Table 1 in
[34]) are identified by our top text mining results,
including BRAF, RET, TP53, TRK (NTRK1), RAS
(RASA1), PAX8-PPARG, RET/PTC (PTCH1), PTEN and
AKT. The only missing gene PIK3CA is ranked 30th and
32nd in the lists for FTC and ATC, respectively. This
provides solid evidence for the capability of our method
in assisting systematic acquisition of knowledge of the
molecular biology of thyroid cancer.
We also compared the subtype gene lists generated by
text mining to the manually created TCGDB database
Table 2 Number of articles for each subtype in the
TC_TEXT corpus.
PTC ATC FTC MTC XTC* TOTAL
#Articles 7795 1122 4696 3316 3768 26866
% 29.0% 4.2% 17.5% 12.3% 14.0%
Incidence§ 75% 1-2% 10-15% 5-10%
XTC*: represents articles that contain more than one subtype labels.
Incidence§ data source: PTC, FTC, ATC [2], MTC [39]
Figure 3 Overlap of documents related to different TC
subtypes. The Venn diagram illustrates the overlap between
documents associated to different subtypes.
Figure 4 Comparison between text-mined TC genes and
Gene2PubMed. This Venn diagram compares the text-mined genes
(TM) to a manually annotated database Gene2PubMed (PM). The
figure demonstrates a good coverage by text-mining and it also shows
that text mining could be more comprehensive.
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(see Table 6): only a small number of genes for each
subtype were missed by our method. The majority of
the genes in the subtype lists from TCGDB have been
successfully retrieved by our method, along with a num-
ber of candidates for further manual curation.
Figure 5 shows a Venn diagram of gene lists shared
between the four subtypes. Compared to Figure 3, we
observe a much higher degree of overlap among sub-
types. This indicates that a considerable number of
common genes are investigated across different subtypes
but in separate studies. Meanwhile, each subtype is still
characterized by a significant number of unique genes.
Pathway mention recognition results
Table 7 presents the top 20 pathways for each TC sub-
type (For the complete text mining results for TC
related pathways, please refer to Additional File 5). The
most frequently mentioned pathways are typical biologi-
cal processes involved in most cancers, including apop-
tosis, angiogenesis, cell cycle, etc.
To validate these results, we compiled a list of path-
ways from the most recent review on the molecular
biology of thyroid cancers mentioned above [34]. The
list includes five pathways: the mitogen-activated protein
kinase (MAPK) pathway, the phosphatidylinositol
3-kinase (PI3K)/Akt signaling pathway, the Wnt/beta-
catenin pathway, the NF-kB pathway and the Hypoxia-
Inducible Factor (HIF)-1a pathway. Except for the
HIF-1a pathway, all other pathways are present in the
top 20 pathways extracted for subtypes by text mining
(see Table 8). The HIF-1a pathway was reported to be a
potential therapeutic target for thyroid cancer [35] and
Table 3 Results of TC-relevance for 50 sampled text-mined genes not in Gene2PubMed.
Gene Freq. Related to TC? PMID Gene Freq. Related to TC? PMID
ENO2 78 YES 6342746 MUC5B 2 NO N/A
SYP 37 YES 11740050 ADA 2 YES 5694958
ALB 36 YES 591616 MIR34A 2 YES 24220341
CDK2 20 YES 23895847 MAPK10 2 YES 15619007
SHBG 12 YES 12705335 APOD 2 YES 14764826
LMOD1 9 YES 17914110 WNT7A 1 YES 16676402
P4HB 7 NO N/A TSHZ3 1 NO N/A
SLC2A3 7 YES 18571834 PMS2L11 1 YES 21606360
THY1 7 NO N/A FH 1 NO N/A
PCSK2 6 YES 18661512 NQO2 1 YES 23918565
TNFRSF10B 6 YES 22113498 MAP3K5 1 YES 20410161
AOC1 5 YES 191838 HYOU1 1 YES 20719828
ETS1 5 YES 11280797 VCP 1 YES 16189643
AFP 4 YES 12428567 NDRG4 1 NO N/A
CD14 4 YES 11389034 CLDN3 1 YES 21606360
STAT5A 3 YES 21136677 COX6A1 1 YES 23569218
STMN1 3 YES 15613457 RAPGEF3 1 YES 11375794
PRKAA2 3 YES 24196587 GNA11 1 YES 24137342
TAM 3 YES 8077333 MIR603 1 NO N/A
CTLA4 3 YES 18505566 TAT 1 NO N/A
APOE 2 YES 17690558 MLN 1 YES 18844033
HBEGF 2 YES 23917679 FKBP4 1 YES 22612312
SNAP25 2 YES 18813355 EPAS1 1 YES 20578836
TRHR 2 YES 23781307 MFI2 1 YES 8090582
YY1 2 YES 23690926 KLF4 1 YES 23301671
The PMID column shows an example of document that reports evidence that a given gene is linked to TC, or N/A if we were not able to find support for the
relationship.
Table 4 Number of genes extracted for each TC subtype.
PTC ATC FTC MTC TOTAL
#Genes 1256 538 791 613 2834
%Unique 38.7% 25.5% 15.8% 40.6%
%Unique represents the percentage of (unique) genes that appear only with a given subtype (compared to the total number of genes appearing with that
subtype). So, 38.7% of genes related to PTC are unique to PTC i.e. appear only with PTC and not with other subtypes.
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has been experimentally verified in a couple of cell lines
[36]. However, this pathway is absent from the text-
mined results, even though the reporting paper [36] was
included in TC_TEXT corpus. Our method did detect
the HIF-1a pathway mention and found its association
with thyroid carcinomas. However, the subtype rele-
vancy scores for that abstract (PMID: 19808899) are
low. The reason is that the cell lines used in the study
were actually subtype-specific but this information was
only available in the full-text. This example suggests the
importance and potential of the analysis of full text arti-
cles as opposed to abstracts, which is an objective for
future work.
For other pathways in Table 7 that have not been
mentioned in the above review, we have further investi-
gated whether they are associated with the correspond-
ing subtypes. For instance, the Notch signalling appears
in the top 20 pathways for PTC, ATC and MTC but
was not mentioned in [34]. We however found direct
literature evidence that links this pathway to TC: the
Notch pathway has crosstalk with the MAPK pathway
and affects the PTC proliferation [37], and the activation
of the Notch signalling has been identified as the poten-
tial therapeutic strategy for ATC [38]. We followed this
procedure for each pathway in Table 7: an example
PMID is given in the “Evidence” column, which repre-
sents an article that reports the association between the
subtype and the pathway (if applicable). Almost all
Table 5 Top 20 genes for the four thyroid cancer subtypes as extracted from the literature.
PTC ATC FTC MTC







#1 TG 5471 TP53 645 TG 4246 CALCA 6173
#2 RET 4916 TG 424 TSHB 1039 RET 3880
#3 BRAF 2582 AKT1 274 RET 585 SST 1016
#4 PTCH1 1829 CDKN1A 231 PAX8 453 TG 547
#5 TSHB 1175 EGFR 228 TSHR 435 CEACAM3 462
#6 NCOA4 1115 CASP3 213 BRAF 419 GAST 367
#7 RASA1 914 BRAF 209 RASA1 392 CEACAM19 365
#8 TP53 819 RET 179 PPARG 374 CHGA 353
#9 LGALS3 693 PAX8 151 LGALS3 364 POMC 334
#10 KRT19 662 RASA1 151 TP53 333 TXK 325
#11 MAPK1 658 BCL2 144 CALCA 272 ENO2 260
#12 TSHR 570 CCND1 141 TPO 266 NTRK1 224
#13 CCDC6 557 VIM 137 PPBP 235 RASA1 209
#14 NTRK1 422 VEGFA 121 AKT1 222 TP53 206
#15 HBE1 386 NKX2-1 120 KRT19 193 EGFR 177
#16 NKX2-1 384 CALCA 119 PTEN 174 ELL 177
#17 AKT1 371 PARP1 111 EGF 173 AKT1 169
#18 VEGFA 369 TXK 111 PPARA 167 KDR 162
#19 PPBP 343 PPARG 108 NKX2-1 156 SSTR1 161
#20 MET 329 SLC5A5 107 EGFR 150 BCL2 147
Table 6 Text-mined genes compared with the TCGDB
database.
PTC ATC FTC MTC
#TCGDB 60 15 10 20
#TM Missed 8 2 3 2
%Coverage 86.7% 86.7% 70% 90%
The first row represents the total numbers of genes in TCGDB associated to a
given subtype. The second row represents the number of genes missed by
text mining. The final row is the coverage: (#TCGDB-#TM Missed) / #TCGDB.
Figure 5 Overlap of genes associated to different TC subtypes.
This figure shows a Venn diagram of gene lists for the four
subtypes and their overlap.
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pathways in the top 20 list are supported by literature
evidence: only for five pathways in the FTC list we were
not able to find support in the literature. This demon-
strates the potential of our work for the systematic and
comprehensive acquisition of knowledge of thyroid
cancer.
Conclusions
In this paper we presented an approach to finding mole-
cular information associated with different subtypes of
thyroid cancer. We developed a method for subtype
classification and performed text mining to identify
genes and biological pathways associated with each
subtype. The generated gene and pathway lists provide a
comprehensive compendium of the key molecular infor-
mation related to thyroid cancer subtypes.
The data and results from our study form the basis
for a further comprehensive analysis of the molecular
biology of thyroid cancer, enriched by subtypes. Based
on the molecular differences between subtypes revealed
in our study, biologists can look for better diagnostic
biomarkers. In addition, the molecular information can
be used to build molecular networks of thyroid cancer
subtypes, which would enable further systems biology
analyses and stimulate the development of targeted
therapeutics.
Table 7 Top 20 pathways for the four thyroid cancer subtypes as extracted from the literature.
Top PTC ATC FTC MTC
Pathway Evidence Pathway Evidence Pathway Evidence Pathway Evidence
#1 Apoptosis 22120515 Apoptosis 20067110 Apoptosis 24213562 Apoptosis 10614665
#2 Cell cycle 23231932 Cell cycle 22688732 Angiogenesis 14605010 Cell cycle 21973234
#3 MAPK pathway 23544999 Angiogenesis 17575107 Cell cycle 19190121 Angiogenesis 20133461
#4 Angiogenesis 23528368 PI3K/Akt pathway 22918703 PI3K/Akt pathway 18492751 RET pathway 15316058
#5 DNA Repair 21860547 MAPK pathway 17989125 DNA Repair 22331172 mTOR pathway 22136849
#6 S Phase 22329804 S Phase 18813835 S Phase 2874658 S Phase 18791128
#7 PI3K/Akt pathway 22744707 M Phase 22399519 MAPK pathway 18492751 Focal Adhesion 12850460
#8 Glucose transport 21606885 NF-kB pathway 19158360 PI3K pathway 23128507 MAPK pathway 15746253





23261982 Focal Adhesion 19293266 Oxidative Stress 22331172 Notch1 pathway 18520232
#11 TGF-beta pathway 21874046 Wnt pathway 15650354 TGF-beta pathway 10942134 bone remodeling 6611007
#12 mTOR pathway 21822208 Glycolysis 3155492 Glucose transport 16273245 mRNA Processing 2582437
#13 Oxidative Stress 9774495 Notch1 pathway 23594881 thyroid hormone
production
N/A Raf-1 pathway 17363508
#14 MAPK/ERK pathway 22426956 G1 Phase 9038381 Glucose metabolism 19433487 PI3K pathway 17188151
#15 MEK/ERK pathway 20629553 mTOR pathway 20689131 cAMP pathway N/A Notch pathway 20182588




N/A ERK activation 21470995
#17 Focal Adhesion 22513979 STAT3 pathway 22328572 Cytokinesis 15886755 PI3K/Akt pathway 23934677
#18 Notch pathway 23544172 Wnt/beta-catenin
pathway
17218945 Hedgehog (Hh) pathway N/A Glucose transport 9426419
#19 Glycolysis 23846818 p21 pathway 22918703 Glycolysis N/A EGFR pathway 22025146
#20 Glucose metabolism 20473281 Rb/E2F pathway 15118916 VEGF pathway 18509004 Glycolysis 3155492
“Evidence” column presents one example PMID that reports a given relationship (N/A: Not Applicable if there is no evidence)
Table 8 Reviewed TC related pathways and text-mined evidence for each subtype.
Pathway Related to TC? Evidence PMIDs
PTC ATC FTC MTC
MAPK pathway YES 16896265 16410725 21196179 23934677
PI3K/Akt signaling pathway YES 18000091 22918703 17426084 23329180
Wnt/beta-catenin pathway YES 22204713 17218945 18727708 N/A
NF-kB pathway YES 23528368 19885592 16314832 N/A
HIF-1a pathway YES N/A N/A N/A N/A
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Availability
The code and data files are available at https://github.com/
chengkun-wu/GenesThyCan.
Additional material
Additional File 1: TC_TEXT PMID list. The PMIDs in the TC_TEXT
corpus are listed in this .txt file, one PMID per line.
Additional File 2: SC_GOLD PMID list. The .txt file is the gold standard
derived from the MeSH Supplementary Concepts for thyroid cancer. It
consists of 1,213 PMIDs and their corresponding thyroid cancer SCs. The
values in the file are tab separated.
Additional File 3: Classification results with scores and subtype
labels. The .xlsx (Excel) file contains the classification results on the
TC_TEXT corpus with subtype relevancy scores and predicated subtype
labels. If a document is not related to TC at all, it is given the label
“NON"; if a document is related to TC but without a specific focus on
one or multiple subtypes, it is given the label “TC"; if a document is
assigned multiple subtype labels, the labels are separated by ‘|’.
Additional File 4: Text-mined gene results. The .xlsx (Excel) file
contains the text mining results for TC-related genes. The file contains a
mapping between TC-related documents and their associated genes,
categorized by subtypes.
Additional File 5: Text-mined pathway results. The .xlsx (Excel) file
contains the text mining results for TC-related pathways. The file contains
a mapping between TC-related documents and their associated
pathways, categorized by subtypes.
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